Identification of Genomic Changes in Families Having Multiple Members With Tumors
Status: | Recruiting |
---|---|
Conditions: | Brain Cancer |
Therapuetic Areas: | Oncology |
Healthy: | No |
Age Range: | 18 - Any |
Updated: | 4/21/2016 |
Start Date: | March 2015 |
End Date: | January 2020 |
Contact: | Norissa Honea, RN, DNP |
Email: | norissa.honea@dignityhealth.org |
Phone: | 602-406-6267 |
This study will compare genomic alterations between the parents and the patients with
high-grade glioma.
high-grade glioma.
Genomic changes leading to the formation of brain tumors are slowly being discovered.
Despite advances in genomic technology, much analysis is hindered by the lack of control
samples that could better delineate genomic alterations leading to disease. The ideal
genomic control would be the genetic material of the parents of afflicted individuals. The
researchers propose to then compare the genomic material from parents of siblings, both of
whom have a diagnosis of a high-grade glioma. Additionally, the researchers will then
compare the genomic alterations between the parents and the patients. This analysis will
provide an unprecedented insight into genomic level changes that take place between parents
and patients that resulted in the formation of a high-grade glioma.
Despite advances in genomic technology, much analysis is hindered by the lack of control
samples that could better delineate genomic alterations leading to disease. The ideal
genomic control would be the genetic material of the parents of afflicted individuals. The
researchers propose to then compare the genomic material from parents of siblings, both of
whom have a diagnosis of a high-grade glioma. Additionally, the researchers will then
compare the genomic alterations between the parents and the patients. This analysis will
provide an unprecedented insight into genomic level changes that take place between parents
and patients that resulted in the formation of a high-grade glioma.
Inclusion Criteria:
- 18 years or older.
- Family history of brain tumor in first degree relative
Exclusion Criteria:
- less than 18 years
We found this trial at
1
site
Phoenix, Arizona 85013
Principal Investigator: Peter Nakaji, MD
Phone: 602-406-6267
Click here to add this to my saved trials